• Skip to primary navigation
  • Skip to main content
  • Skip to primary navigation
  • Skip to main content
Choose which site to search.
UAMS Health Logo UAMS Health
  • UAMS.edu
  • MyChart
  • Giving
  • Emergency Room
  • COVID-19
  • Types of Care
  • Locations
  • Doctors
  • Patients & Guests
  • Referring Physicians
  • Appointments
  1. UAMS Health
  2. Conditions
  3. Monoclonal Gammopathy of Unknown Significance (MGUS)

Condition: Monoclonal Gammopathy of Unknown Significance (MGUS)

Monoclonal Gammopathy of Undetermined Significance (MGUS) is a non-cancerous, or benign, condition characterized by the presence in the blood of an abnormal protein produced by plasma cells. Plasma cells, found in the bone marrow and in blood, normally produce antibodies that fight infection.

The abnormal protein is referred to as an M–protein or paraprotein. It is monoclonal, which means that it is produced by one family of cells that are all identical copies of each other.

MGUS is considered a benign condition, since there is only a small risk that it will develop into myeloma or a related blood cancer. An increase in paraprotein in the bone marrow is often the first sign of progression from MGUS to active myeloma. This excess of the paraprotein impedes the production of healthy blood cells and antibodies that fight infection.

Key Statistics and Risk Factors

The risk of MGUS increases with age. Approximately 3% of adults 50 and older and 5% of adults 70 and older have M-protein in their blood. The highest incidence is among adults 85 and older.

MGUS is about 1.5 times more common in men than in women and is nearly twice as common in African-Americans as in Caucasians.

Signs and Symptoms

There are usually no obvious symptoms associated with MGUS. Occasionally, people with MGUS have numbness or tingling in their hands and feet (peripheral neuropathy), or problems with their balance. This may be due to nerve damage caused by the paraprotein in the blood.

Patients with MGUS should watch for any symptoms, such as bone pain and fatigue, as they might indicate progression to myeloma.

Diagnosing MGUS

MGUS is usually detected incidentally during a routine check-up when a blood test shows an increase in the blood protein level. The diagnosis is then confirmed by having a particular blood test called serum electropheresis which identifies the abnormal antibody.

MGUS is clinically defined as having a paraprotein level of less than 3 grams per deciliter and less than 10 percent plasma cells in the bone marrow. There is no damage to bones, calcium levels are normal, little or no protein is present in the urine, kidney function is normal and there is no anemia (which can result from a low red blood cell count).

Treatment

MGUS does not usually require treatment. In most people, MGUS remains stable and does not ever cause any problems. However, because MGUS can develop into myeloma, regular check-ups are important.

Research at the Myeloma Center suggests that some patients with MGUS are at increased risk for progression to myeloma. Risk is based on clinical variables, such as blood protein levels and results of gene expression profiling and magnetic resonance imaging. In some cases, treatment aimed at preventing progression to active myeloma is indicated.

Prognosis

MGUS is generally considered benign and has no ill effects on overall health or survival. However, regular check-ups are essential, since myeloma typically develops in 1% to 2% of MGUS patients per year. It is important for patients to contact their doctor between check-ups if they develop any new symptoms.

Future

Our expert scientists at the Myeloma Center are researching what causes the progression of MGUS to myeloma, the genetics of MGUS and myeloma and whether personalized treatment may prevent the progression.

Contents

  • Treatments & Procedures
  • Providers
  • Locations
  • Areas of Expertise
  • Make an Appointment

Treatments and Procedures Related to Monoclonal Gammopathy of Unknown Significance (MGUS)

UAMS providers perform and prescribe a broad range of treatments and procedures, some of which may not be listed below.

  • Advanced Diagnostics
  • Total Therapy Approach

Providers Treating Monoclonal Gammopathy of Unknown Significance (MGUS)

Note that every provider listed below may not perform or prescribe all treatments or procedures related to Monoclonal Gammopathy of Unknown Significance (MGUS). Review each provider for availability.

Filter the Providers


Samer A. Al'Hadidi, M.D.

Samer A. Al'Hadidi, M.D. Hematologist/Oncologist

View Profile
Carolina D. Schinke, M.D.

Carolina D. Schinke, M.D. Hematologist/Oncologist

View Profile
Sharmilan Thanendrarajan, M.D., Ph.D.

Sharmilan Thanendrarajan, M.D., Ph.D. Hematologist/Oncologist

View Profile
Frits van Rhee, M.D., Ph.D.

Frits van Rhee, M.D., Ph.D. Hematologist/Oncologist

View Profile
Maurizio Zangari, M.D.

Maurizio Zangari, M.D. Hematologist/Oncologist

View Profile

Locations Where Providers Treat Monoclonal Gammopathy of Unknown Significance (MGUS)

Note that the treatment of Monoclonal Gammopathy of Unknown Significance (MGUS) may not be performed at every location listed below. The list may include locations where the treatment plan is developed during and after a patient visit.

Filter the Locations


Myeloma Center

Myeloma Center

449 Jack Stephens Drive
Winthrop P. Rockefeller Cancer Institute
Little Rock, AR 72205

Appointment Phone Numbers
501-686-7105
New Patients
501-686-8230
Returning Patients
View Location Get Directions

Areas of Expertise for Monoclonal Gammopathy of Unknown Significance (MGUS)

Image of male doctor giving intravenous drip chemotherapy treatment to a female cancer patient.

Cancer Care

The UAMS Winthrop P. Rockefeller Cancer Institute is Arkansas’ most comprehensive cancer treatment and research facility.

View Area of Expertise
Multiple Myeloma Center at UAMS

Myeloma Care (Part of Cancer Care)

The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma.

View Area of Expertise

Make an Appointment

Request an appointment by contacting a clinic directly or by calling the UAMS Health appointment line at (501) 686-8000.

UAMS Health LogoUAMS HealthUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement
  • Notice of Privacy Practices

© 2023 University of Arkansas for Medical Sciences

Please share your location to continue